Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Boey

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Science (London, England : 1979)|January 24, 2018
Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodellingBianca C Bernardo, Kate L Weeks, Thawin Pongsukwechkul, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2012
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart functionBianca C Bernardo, Xiao-Ming Gao, Catherine E Winbanks, et al.
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Plos One|March 4, 2014
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathyBianca C Bernardo, Xiao-Ming Gao, Yow Keat Tham, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2014
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophyBianca C Bernardo, Sally S Nguyen, Catherine E Winbanks, et al.
Circulation. Heart Failure|June 19, 2012
Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunctionKate L Weeks, Xiaoming Gao, Xiao-Jun Du, et al.
Nature Communications|December 10, 2014
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in miceGeeta Sapra, Yow Keat Tham, Nelly Cemerlang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Science (London, England : 1979)|January 24, 2018
Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodellingBianca C Bernardo, Kate L Weeks, Thawin Pongsukwechkul, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2012
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart functionBianca C Bernardo, Xiao-Ming Gao, Catherine E Winbanks, et al.
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Plos One|March 4, 2014
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathyBianca C Bernardo, Xiao-Ming Gao, Yow Keat Tham, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2014
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophyBianca C Bernardo, Sally S Nguyen, Catherine E Winbanks, et al.
Circulation. Heart Failure|June 19, 2012
Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunctionKate L Weeks, Xiaoming Gao, Xiao-Jun Du, et al.
Nature Communications|December 10, 2014
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in miceGeeta Sapra, Yow Keat Tham, Nelly Cemerlang, et al.
Pageof 2